ACRX
AcelRx Pharmaceuticals, Inc.

Market cap $98.789M
Enterprise value $53.258M
Employees 42
Revenue $13.7M
EBITDA -$36.1M
Income -$51.3M
EPS -1.13
P/E N/A
Forward P/E -1.92
EV/EBITDA -1.48
PEG N/A
Earnings date 2017-10-30
Volume 201k / 2.01M
Relative vol. 0.10 ×
Profit margin 0.00%
Oper. margin -277.67%
Gross margin 36.83%
Sales Q/Q -76.89%
Sales Y/Y 129.67%
Est. EPS Q/Q N/A
Beta 2.81
Mean Recomm. 2.40
IPO year 2011
Country United States
RSI 43.08
Range $1.95 – $2.20
52 weeks $1.55 – $5.75
SMA 50 $2 +4.57%
SMA 200 $3 +41.96%
1 year target $4 +117.95%

Intraday

5 days

1 month

3 months

6 months

1 year

5 years

10 years

All time

Messenger